**VK2735 for Weight Management in Type 2 Diabetes Study** This study is testing a new medicine, VK2735, for people with Type 2 Diabetes who are also overweight or obese. The main goal is to see if this medicine helps people lose weight safely. The study will last about **78 weeks**, which is almost a year and a half. During this time, participants will not know if they are getting the real medicine or a placebo, which is a harmless pill that looks like the real thing. This is called a *double-blind, placebo-controlled* study. Participants must be **18 years or older** and have a body mass index (BMI) of **27 or more**. The BMI measures if a person's weight is healthy for their height. They should also have Type 2 Diabetes, with specific blood sugar levels, and have been on stable treatment for at least the last three months. Key Points: - **Duration**: The study will last for 78 weeks. - **Visits**: Participants may need to visit the study site multiple times. - **Treatment**: It includes taking either the study medicine or a placebo. Participants should not have certain other health issues or recent significant weight changes.